1. Home
  2. UPBD vs EVO Comparison

UPBD vs EVO Comparison

Compare UPBD & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPBD
  • EVO
  • Stock Information
  • Founded
  • UPBD 1986
  • EVO 1993
  • Country
  • UPBD United States
  • EVO Germany
  • Employees
  • UPBD N/A
  • EVO N/A
  • Industry
  • UPBD Diversified Commercial Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • UPBD Consumer Discretionary
  • EVO Health Care
  • Exchange
  • UPBD Nasdaq
  • EVO Nasdaq
  • Market Cap
  • UPBD 1.5B
  • EVO 1.2B
  • IPO Year
  • UPBD 1995
  • EVO 2021
  • Fundamental
  • Price
  • UPBD $25.02
  • EVO $3.47
  • Analyst Decision
  • UPBD Buy
  • EVO Buy
  • Analyst Count
  • UPBD 4
  • EVO 2
  • Target Price
  • UPBD $34.50
  • EVO $5.40
  • AVG Volume (30 Days)
  • UPBD 587.5K
  • EVO 45.3K
  • Earning Date
  • UPBD 10-30-2025
  • EVO 11-05-2025
  • Dividend Yield
  • UPBD 6.24%
  • EVO N/A
  • EPS Growth
  • UPBD 78.87
  • EVO N/A
  • EPS
  • UPBD 1.79
  • EVO N/A
  • Revenue
  • UPBD $4,481,986,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • UPBD $9.99
  • EVO $0.43
  • Revenue Next Year
  • UPBD $8.44
  • EVO $9.72
  • P/E Ratio
  • UPBD $13.96
  • EVO N/A
  • Revenue Growth
  • UPBD 7.49
  • EVO N/A
  • 52 Week Low
  • UPBD $19.65
  • EVO $2.84
  • 52 Week High
  • UPBD $36.00
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • UPBD 52.91
  • EVO 41.34
  • Support Level
  • UPBD $24.39
  • EVO $3.40
  • Resistance Level
  • UPBD $25.59
  • EVO $3.55
  • Average True Range (ATR)
  • UPBD 0.65
  • EVO 0.07
  • MACD
  • UPBD -0.01
  • EVO 0.02
  • Stochastic Oscillator
  • UPBD 34.81
  • EVO 42.31

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: